MedPath

Tetrabenazine

These highlights do not include all the information needed to use TETRABENAZINE TABLETS safely and effectively. See full prescribing information for TETRABENAZINE TABLETS. TETRABENAZINE tablets, for oral use Initial U.S. Approval: 2008

Approved
Approval ID

b7d93006-7f06-4da4-985e-6b948c2468e8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 6, 2023

Manufacturers
FDA

Sun Pharmaceutical Industries, Inc.

DUNS: 146974886

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tetrabenazine

PRODUCT DETAILS

NDC Product Code47335-179
Application NumberANDA206129
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 10, 2023
Generic NameTetrabenazine

INGREDIENTS (8)

TETRABENAZINEActive
Quantity: 25 mg in 1 1
Code: Z9O08YRN8O
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

Tetrabenazine

PRODUCT DETAILS

NDC Product Code47335-277
Application NumberANDA206129
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 10, 2023
Generic NameTetrabenazine

INGREDIENTS (7)

TETRABENAZINEActive
Quantity: 12.5 mg in 1 1
Code: Z9O08YRN8O
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

Drug Labeling Information

Boxed Warning Section

LOINC: 34066-1Updated: 9/1/2023

WARNING: DEPRESSION AND SUICIDALITY****
See full prescribing information for complete boxed warning.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tetrabenazine - FDA Drug Approval Details